177 related articles for article (PubMed ID: 23968815)
1. Effects of methamphetamine on the noradrenergic activity biomarker salivary alpha-amylase.
Haile CN; De La Garza R; Mahoney JJ; Newton TF
Drug Alcohol Depend; 2013 Dec; 133(2):759-62. PubMed ID: 23968815
[TBL] [Abstract][Full Text] [Related]
2. Caffeine administration does not alter salivary α-amylase activity in young male daily caffeine consumers.
Klein LC; Whetzel CA; Bennett JM; Ritter FE; Nater UM; Schoelles M
BMC Res Notes; 2014 Jan; 7():30. PubMed ID: 24410993
[TBL] [Abstract][Full Text] [Related]
3. Norepinephrine infusion with and without alpha-adrenergic blockade by phentolamine increases salivary alpha amylase in healthy men.
Kuebler U; von Känel R; Heimgartner N; Zuccarella-Hackl C; Stirnimann G; Ehlert U; Wirtz PH
Psychoneuroendocrinology; 2014 Nov; 49():290-8. PubMed ID: 25128931
[TBL] [Abstract][Full Text] [Related]
4. Salivary alpha-amylase and noradrenaline responses to corticotropin-releasing hormone administration in humans.
Petrakova L; Boy K; Mittmann L; Möller L; Engler H; Schedlowski M
Biol Psychol; 2017 Jul; 127():34-39. PubMed ID: 28472693
[TBL] [Abstract][Full Text] [Related]
5. Acute stress responses in salivary alpha-amylase predict increases of plasma norepinephrine.
Thoma MV; Kirschbaum C; Wolf JM; Rohleder N
Biol Psychol; 2012 Dec; 91(3):342-8. PubMed ID: 22954623
[TBL] [Abstract][Full Text] [Related]
6. Salivary α-amylase response to endotoxin administration in humans.
Grigoleit JS; Kullmann JS; Oberbeck R; Schedlowski M; Engler H
Psychoneuroendocrinology; 2013 Sep; 38(9):1819-23. PubMed ID: 23394872
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of subjective effects of aripiprazole and methamphetamine in methamphetamine-dependent volunteers.
Newton TF; Reid MS; De La Garza R; Mahoney JJ; Abad A; Condos R; Palamar J; Halkitis PN; Mojisak J; Anderson A; Li SH; Elkashef A
Int J Neuropsychopharmacol; 2008 Dec; 11(8):1037-45. PubMed ID: 18664303
[TBL] [Abstract][Full Text] [Related]
8. Norepinephrine transporter blocker atomoxetine increases salivary alpha amylase.
Warren CM; van den Brink RL; Nieuwenhuis S; Bosch JA
Psychoneuroendocrinology; 2017 Apr; 78():233-236. PubMed ID: 28232237
[TBL] [Abstract][Full Text] [Related]
9. Salivary alpha-amylase as a non-invasive biomarker for the sympathetic nervous system: current state of research.
Nater UM; Rohleder N
Psychoneuroendocrinology; 2009 May; 34(4):486-96. PubMed ID: 19249160
[TBL] [Abstract][Full Text] [Related]
10. Comparison of noradrenaline, dopamine and serotonin in mediating the tachycardic and thermogenic effects of methamphetamine in the ventral medial prefrontal cortex.
Hassan SF; Zumut S; Burke PG; McMullan S; Cornish JL; Goodchild AK
Neuroscience; 2015 Jun; 295():209-20. PubMed ID: 25813709
[TBL] [Abstract][Full Text] [Related]
11. Effects of stress on responses to methamphetamine in humans.
Söderpalm A; Nikolayev L; de Wit H
Psychopharmacology (Berl); 2003 Nov; 170(2):188-99. PubMed ID: 12845405
[TBL] [Abstract][Full Text] [Related]
12. Associations between salivary alpha-amylase and catecholamines--a multilevel modeling approach.
Ditzen B; Ehlert U; Nater UM
Biol Psychol; 2014 Dec; 103():15-8. PubMed ID: 25132576
[TBL] [Abstract][Full Text] [Related]
13. Subjective and Cardiovascular Effects of Intravenous Methamphetamine during Perindopril Maintenance: A Randomized, Double-Blind, Placebo-Controlled Human Laboratory Study.
Verrico CD; Haile CN; De La Garza R; Grasing K; Kosten TR; Newton TF
Int J Neuropsychopharmacol; 2016 Jul; 19(7):. PubMed ID: 27207905
[TBL] [Abstract][Full Text] [Related]
14. Elevated Activity of the Sympathetic Nervous System Is Related to Diminished Practice Effects in Memory: A Pilot Study.
Pagen LHG; Smeets T; Schmiedek L; Yassa MA; Verhey FRJ; Jacobs HIL
J Alzheimers Dis; 2021; 80(4):1675-1685. PubMed ID: 33720881
[TBL] [Abstract][Full Text] [Related]
15. Effects of strategic early-morning caffeine gum administration on association between salivary alpha-amylase and neurobehavioural performance during 50 h of sleep deprivation.
Pajcin M; White JM; Banks S; Dorrian J; Paech GM; Grant CL; Johnson K; Tooley K; Aidman E; Fidock J; Kamimori GH; Della Vedova CB
Accid Anal Prev; 2019 May; 126():160-172. PubMed ID: 29402402
[TBL] [Abstract][Full Text] [Related]
16. Decreased salivary alpha-amylase levels are associated with performance deficits during sleep loss.
Pajcin M; Banks S; White JM; Dorrian J; Paech GM; Grant C; Johnson K; Tooley K; Fidock J; Kamimori GH; Della Vedova CB
Psychoneuroendocrinology; 2017 Apr; 78():131-141. PubMed ID: 28196342
[TBL] [Abstract][Full Text] [Related]
17. Determinants of salivary alpha-amylase in humans and methodological considerations.
Rohleder N; Nater UM
Psychoneuroendocrinology; 2009 May; 34(4):469-85. PubMed ID: 19155141
[TBL] [Abstract][Full Text] [Related]
18. Reduction in salivary α-amylase levels following a mind-body intervention in cancer survivors--an exploratory study.
Lipschitz DL; Kuhn R; Kinney AY; Donaldson GW; Nakamura Y
Psychoneuroendocrinology; 2013 Sep; 38(9):1521-31. PubMed ID: 23375640
[TBL] [Abstract][Full Text] [Related]
19. α-Amylase as a reliable and convenient measure of sympathetic activity: don't start salivating just yet!
Bosch JA; Veerman EC; de Geus EJ; Proctor GB
Psychoneuroendocrinology; 2011 May; 36(4):449-53. PubMed ID: 21295411
[TBL] [Abstract][Full Text] [Related]
20. Salivary alpha amylase as marker for adrenergic activity during stress: effect of betablockade.
van Stegeren A; Rohleder N; Everaerd W; Wolf OT
Psychoneuroendocrinology; 2006 Jan; 31(1):137-41. PubMed ID: 16046076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
